GERGEN MARK J (President and CBO) sold 4.4% of their position (30K shares) of POSEIDA THERAPEUTICS, INC. on the open market
Open‑market sale worth $278.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/27/2024ACC: 0000950170-24-131665
DirectorOfficer· President and CBO
Since Jul 2020
-30K
Net shares
Net seller
$278.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
30K acquired · 60K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+30K
Price / share
$2.78
Trade value
$83.43K
% of position
4.6%
11/26/2024
651.29K→681.29K
Common Stock
Direct
Shares
−30K
Price / share
$9.27
Trade value
$278.10K
% of position
4.4%
11/26/2024
681.29K→651.29K
Total
Net shares
+0.00
Net value
-$194.67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/26/2024 | M · Option Exercise | +30K | $2.78 | $83.43K | 4.6% | 651.29K | 681.29K |
| Common Stock Direct | 11/26/2024 | S · Sale | −30K | $9.27 | $278.10K | 4.4% | 681.29K | 651.29K |
| Total | +0.00 | -$194.67K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
30K shares
Shares
−30K
Strike price
2.781
Held after
126.37K
Exercisable
—
11/26/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock30K shares | 11/26/2024 | M · Option Exercise | −30K | 2.781 | — | 126.37K |